Acutaas Chemicals Q1 FY27: 59% Revenue Growth, 45% PAT Drop, Shares Dip 7%Acutaas Chemicals Q1 FY27: 45% PAT drop amid 59% revenue surge, 7% intraday sell‑off, yet 180% YTD stock gain signals long‑term resilience.Acutaas Chemicals Limited Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 25/07/2026, 09:09 2 minutes to read